SRDX logo

Surmodics (SRDX) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$36.12 M
-$5.30 M-12.81%

September 30, 2024


Summary


Performance

SRDX Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSRDXbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$30.14 M
-$5.97 M-16.53%

December 31, 2024


Summary


Performance

SRDX Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSRDXbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

SRDX Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-12.8%+29.1%
3 y3 years+15.9%+29.1%
5 y5 years+18.9%+29.1%

SRDX Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-12.8%+90.1%-32.4%+58.7%
5 y5-year-12.8%+90.1%-51.5%+234.7%
alltimeall time-35.0%+2678.1%-54.2%>+9999.0%

Surmodics Cash And Cash Equivalents History

DateAnnualQuarterly
Dec 2024
-
$30.14 M(-16.5%)
Sep 2024
$36.12 M(-12.8%)
$36.12 M(+48.6%)
Jun 2024
-
$24.30 M(-26.4%)
Mar 2024
-
$33.03 M(+41.4%)
Dec 2023
-
$23.36 M(-43.6%)
Sep 2023
$41.42 M(+118.0%)
$41.42 M(-7.1%)
Jun 2023
-
$44.58 M(+132.4%)
Mar 2023
-
$19.18 M(-27.4%)
Dec 2022
-
$26.43 M(+39.1%)
Sep 2022
$19.00 M(-39.0%)
$19.00 M(-5.4%)
Jun 2022
-
$20.07 M(-18.8%)
Mar 2022
-
$24.71 M(-7.3%)
Dec 2021
-
$26.65 M(-14.5%)
Sep 2021
$31.15 M(+1.2%)
$31.15 M(-49.9%)
Jun 2021
-
$62.18 M(+29.1%)
Mar 2021
-
$48.16 M(+34.7%)
Dec 2020
-
$35.75 M(+16.1%)
Sep 2020
$30.79 M(+1.4%)
$30.79 M(-15.4%)
Jun 2020
-
$36.39 M(+139.3%)
Mar 2020
-
$15.21 M(+68.9%)
Dec 2019
-
$9.01 M(-70.3%)
Sep 2019
$30.36 M(+30.2%)
$30.36 M(+5.0%)
Jun 2019
-
$28.92 M(+28.7%)
Mar 2019
-
$22.47 M(+56.0%)
Dec 2018
-
$14.40 M(-38.2%)
Sep 2018
$23.32 M(+41.0%)
$23.32 M(-14.5%)
Jun 2018
-
$27.27 M(-1.6%)
Mar 2018
-
$27.71 M(+28.3%)
Dec 2017
-
$21.60 M(+30.6%)
Sep 2017
$16.53 M(-33.8%)
$16.53 M(+45.7%)
Jun 2017
-
$11.35 M(+0.8%)
Mar 2017
-
$11.26 M(-36.2%)
Dec 2016
-
$17.65 M(-29.4%)
Sep 2016
$24.99 M(-55.0%)
$24.99 M(-27.9%)
Jun 2016
-
$34.66 M(-11.1%)
Mar 2016
-
$38.99 M(-8.6%)
Dec 2015
-
$42.67 M(-23.2%)
Sep 2015
$55.59 M(+27.8%)
$55.59 M(+2.7%)
Jun 2015
-
$54.11 M(+80.3%)
Mar 2015
-
$30.02 M(+13.0%)
Dec 2014
-
$26.56 M(-39.0%)
Sep 2014
$43.51 M(+180.8%)
$43.51 M(+9.5%)
Jun 2014
-
$39.73 M(+370.5%)
Mar 2014
-
$8.44 M(-19.7%)
Dec 2013
-
$10.52 M(-32.1%)
Sep 2013
$15.49 M(-0.3%)
$15.49 M(-12.5%)
Jun 2013
-
$17.71 M(-13.8%)
Mar 2013
-
$20.54 M(-4.3%)
Dec 2012
-
$21.46 M(+38.1%)
Sep 2012
$15.54 M(-33.1%)
$15.54 M(-76.4%)
Jun 2012
-
$65.87 M(+9.4%)
Mar 2012
-
$60.18 M(+21.9%)
Dec 2011
-
$49.36 M(+112.6%)
Sep 2011
$23.22 M
$23.22 M(+25.9%)
DateAnnualQuarterly
Jun 2011
-
$18.44 M(+19.0%)
Mar 2011
-
$15.49 M(+8.3%)
Dec 2010
-
$14.31 M(+25.6%)
Sep 2010
$11.39 M(-2.1%)
$11.39 M(+32.2%)
Jun 2010
-
$8.62 M(-22.9%)
Mar 2010
-
$11.17 M(+0.4%)
Dec 2009
-
$11.13 M(-4.4%)
Sep 2009
$11.64 M(-24.3%)
$11.64 M(+102.6%)
Jun 2009
-
$5.74 M(+3.8%)
Mar 2009
-
$5.53 M(-53.8%)
Dec 2008
-
$11.97 M(-22.2%)
Sep 2008
$15.38 M(+11.3%)
$15.38 M(+12.6%)
Jun 2008
-
$13.66 M(-48.9%)
Mar 2008
-
$26.75 M(+78.3%)
Dec 2007
-
$15.00 M(+8.6%)
Sep 2007
$13.81 M(+268.2%)
$13.81 M(+248.8%)
Jun 2007
-
$3.96 M(-34.2%)
Mar 2007
-
$6.02 M(+2484.5%)
Dec 2006
-
$233.00 K(-93.8%)
Sep 2006
$3.75 M(-4.3%)
$3.75 M(+100.6%)
Jun 2006
-
$1.87 M(+18.4%)
Mar 2006
-
$1.58 M(-12.4%)
Dec 2005
-
$1.80 M(-54.0%)
Sep 2005
$3.92 M(+44.7%)
$3.92 M(-21.3%)
Jun 2005
-
$4.98 M(+411.4%)
Mar 2005
-
$974.00 K(-52.6%)
Dec 2004
-
$2.06 M(-24.1%)
Sep 2004
$2.71 M(-32.4%)
$2.71 M(-78.2%)
Jun 2004
-
$12.43 M(+91.5%)
Mar 2004
-
$6.49 M(-18.5%)
Dec 2003
-
$7.96 M(+98.8%)
Sep 2003
$4.01 M(-56.5%)
$4.01 M(-23.8%)
Jun 2003
-
$5.26 M(-0.0%)
Mar 2003
-
$5.26 M(-49.0%)
Dec 2002
-
$10.32 M(+12.1%)
Sep 2002
$9.21 M(+1.8%)
$9.21 M(+44.0%)
Jun 2002
-
$6.39 M(+68.7%)
Mar 2002
-
$3.79 M(+86.2%)
Dec 2001
-
$2.04 M(-77.5%)
Sep 2001
$9.04 M(+498.9%)
$9.04 M(+93.0%)
Jun 2001
-
$4.69 M(+13.1%)
Mar 2001
-
$4.14 M(+183.6%)
Dec 2000
-
$1.46 M(-3.2%)
Sep 2000
$1.51 M(-24.5%)
$1.51 M(+13.9%)
Jun 2000
-
$1.33 M(-49.8%)
Mar 2000
-
$2.64 M(+46.7%)
Dec 1999
-
$1.80 M(-10.0%)
Sep 1999
$2.00 M(+53.8%)
$2.00 M(+81.8%)
Jun 1999
-
$1.10 M(-8.3%)
Mar 1999
-
$1.20 M(+20.0%)
Dec 1998
-
$1.00 M(-23.1%)
Sep 1998
$1.30 M
$1.30 M(-27.8%)
Jun 1998
-
$1.80 M(-89.5%)
Mar 1998
-
$17.10 M

FAQ

  • What is Surmodics annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Surmodics?
  • What is Surmodics annual cash & cash equivalents year-on-year change?
  • What is Surmodics quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Surmodics?
  • What is Surmodics quarterly cash and cash equivalents year-on-year change?

What is Surmodics annual cash & cash equivalents?

The current annual cash & cash equivalents of SRDX is $36.12 M

What is the all time high annual cash & cash equivalents for Surmodics?

Surmodics all-time high annual cash & cash equivalents is $55.59 M

What is Surmodics annual cash & cash equivalents year-on-year change?

Over the past year, SRDX annual cash & cash equivalents has changed by -$5.30 M (-12.81%)

What is Surmodics quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of SRDX is $30.14 M

What is the all time high quarterly cash and cash equivalents for Surmodics?

Surmodics all-time high quarterly cash and cash equivalents is $65.87 M

What is Surmodics quarterly cash and cash equivalents year-on-year change?

Over the past year, SRDX quarterly cash and cash equivalents has changed by +$6.79 M (+29.07%)